Prognostic value of PD-L1 expression and CD68 macrophages in tumor nest of patients with primary gastric cancer

被引:3
|
作者
Zou, Yunlian [1 ,2 ]
Wang, Jinli [2 ,3 ]
Zhang, Jinping [1 ,2 ]
Guo, Qiang [2 ,3 ]
Song, Zhengji [2 ,3 ,4 ]
Tang, Hui [2 ,3 ,4 ]
机构
[1] Kunming Univ Sci & Technol, Peoples Hosp Yunnan Prov 1, Affiliated Hosp, Dept Hematol, Kunming 650032, Yunnan, Peoples R China
[2] Kunming Univ Sci & Technol, Med Fac, Kunming 650504, Yunnan, Peoples R China
[3] Kunming Univ Sci & Technol, Peoples Hosp Yunnan Prov 1, Dept Gastroenterol, Affiliated Hosp, Kunming 650032, Yunnan, Peoples R China
[4] Kunming Univ Sci & Technol, Peoples Hosp Yunnan Prov 1, Affiliated Hosp, Dept Gastroenterol, 157 Jinbi Rd, Kunming 650032, Yunnan, Peoples R China
基金
中国国家自然科学基金;
关键词
gastric cancer; multiplex immunohistochemistry; programmed death receptor ligand 1; cluster of differentiation 68; prognosis biomarker; DEATH-LIGAND; 1; INFILTRATING LYMPHOCYTES; SIGNIFICANT PREDICTOR; CD133; EXPRESSION; SURVIVAL; OVEREXPRESSION; PROGRESSION; CARCINOMA; PATHWAY; MARKER;
D O I
10.3892/ol.2023.14153
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The programmed death receptor 1/programmed death receptor ligand 1 axis (PD-1/PD-L1) is involved in tumor immune escape and is a potential prognostic biomarker and anti-tumor immunotherapy target in patients with gastric cancer (GC). However, the results of studies obtained in recent years have been inconsistent. The present study aimed to determine the possible predictive significance of PD-L1 in conjunction with three proteins linked with PD-L1 regulation in patients with primary GC. In the present study, the PD-L1, human epidermal growth factor receptor 2 (HER2), cluster of differentiation (CD)133 and microphage-associated CD68 expression levels were identified by multiplexed immunohistochemistry and assessed by automated pathological analysis system in 93 GC tumors and neighboring normal tissues arrayed on the same tissue microarray. All four proteins were statistically analyzed in relation to the clinicopathological characteristics. The expression levels of HER2, CD133 and CD68 were considerably higher in cancer tissues compared with neighboring normal tissues (P<0.05), however, the reverse trend was detected for PD-L1 expression (P=0.0577), particularly in tumor nest (TN; P<0.05). There was no significant correlation between the HER2 and CD133 expression levels and clinicopathological factors. However, significant relationships were found between PD-L1 expression and the TNM stage, pathological differentiation and survival status of patients (P<0.05). Moreover, survival time was prolonged in individuals with elevated PD-L1 expression in TN and GC tissues, but no significant correlation was identified (P=0.0881). The CD68 expression level in tumor stroma, but not in TN, was significantly correlated with poor pathological differentiation in patients with GC (P<0.05). However, PD-L1+CD68+ macrophages were strongly related to lower tumor size (diameter <5 cm), early TNM stage (stage I+II), good pathological differentiation and overall survival in TN (P<0.05). In conclusion, PD-L1+CD68+ macrophage infiltration in TN might be a potential indicator of prognosis in patients with primary GC and merits further investigation.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Clinicopathological and Prognostic Significance of MSI Status and PD-L1 Expression in Turkish Patients with Gastric Cancer
    Bahsi, Seyma
    Yildiz, Ibrahim
    Erdamar, Sibel
    Goksel, Suha
    Tozun, Nurdan
    Aytac, Erman
    Demir, Gokhan
    Er, Ozlem
    Baca, Bilgi
    Karahasanoglu, Tayfun
    Hamzaoglu, Ismail
    Ozer, Leyla
    Bozkurt, Mustafa
    Uras, Cihan
    Bayoglu, Ibrahim Vedat
    Dulgeroglu, Onur
    Ince, Umit
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2021, 31 (04): : 246 - 254
  • [32] Prognostic value of tumor PD-L1 expression combined with CD8+ tumor infiltrating lymphocytes in high grade serous ovarian cancer
    Wang, Qiaohong
    Lou, Weihua
    Di, Wen
    Wu, Xia
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 52 : 7 - 14
  • [33] Macrophages are important source of PD-L1 and PD-L1 expressing in macrophages affect the prognosis of NSCLC patients with tumor PD-L1 negative
    Liu, Y.
    Cao, L.
    Che, X.
    Qiu, X.
    Li, Z.
    Yang, B.
    Wang, S.
    Qu, X.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 531 - 532
  • [34] The expression level and prognostic value of PD-L1 and PD-1 in cervical carcinoma patients
    Bao, Yongxing
    Zhang, Songan
    Niyazi, Huerdidan
    Tuluwengjiang, Gulixian
    Zhang, Lei
    Zhang, Yang
    Su, Weipeng
    CANCER RESEARCH, 2017, 77
  • [35] Changes of CD68, CD163, and PD-L1 tumor expression during high-dose-rate and pulsed-dose-rate brachytherapy for cervical cancer
    Berenguer Frances, Miguel A.
    Linares-Galiana, Isabel
    Canas Cortes, Rut
    Borras, Susanna Marin, I
    Gutierrez Miguelez, Cristina
    Najjari, Dina
    Slocker, Andrea
    Bellobi, Cinta
    Santacana, Maria
    Pane Foix, Maria
    Alonso, M. Henar
    Navarro-Martin, Arturo
    Comas Anton, Silvia
    Guedea, Ferran
    BRACHYTHERAPY, 2020, 19 (01) : 51 - 59
  • [36] PD-L1 expression combined with microsatellite instability/CD8+ tumor infiltrating lymphocytes as a useful prognostic biomarker in gastric cancer
    Toshiaki Morihiro
    Shinji Kuroda
    Nobuhiko Kanaya
    Yoshihiko Kakiuchi
    Tetsushi Kubota
    Katsuyuki Aoyama
    Takehiro Tanaka
    Satoru Kikuchi
    Takeshi Nagasaka
    Masahiko Nishizaki
    Shunsuke Kagawa
    Hiroshi Tazawa
    Toshiyoshi Fujiwara
    Scientific Reports, 9
  • [37] PD-L1 expression combined with microsatellite instability/CD8+tumor infiltrating lymphocytes as a useful prognostic biomarker in gastric cancer
    Morihiro, Toshiaki
    Kuroda, Shinji
    Kanaya, Nobuhiko
    Kakiuchi, Yoshihiko
    Kubota, Tetsushi
    Aoyama, Katsuyuki
    Tanaka, Takehiro
    Kikuchi, Satoru
    Nagasaka, Takeshi
    Nishizaki, Masahiko
    Kagawa, Shunsuke
    Tazawa, Hiroshi
    Fujiwara, Toshiyoshi
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [38] Assessment of PD-L1 Expression in Gastric Tumor Samples
    Scorer, P.
    Barker, C.
    Scott, M.
    Li, W.
    Rebelatto, M.
    Walker, J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (11): : S61 - S61
  • [39] Clinicopathological Characteristics and Prognostic Value of HER2, PD-L1 and MSI Expression in Curative Resectable Gastric Cancer Patients
    Pereira, M. A.
    Ramos, M. F.
    Faraj, S. F.
    Dias, A. R.
    Cirqueira, C. D.
    Charruf, A. Z.
    Perrotta, F. S.
    Mello, E. S.
    Zilberstein, B.
    Cecconello, I.
    Yagi, O. K.
    Alves, V. A.
    Junior, U. R.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S190 - S190
  • [40] Acetaminophen pretreatment stimulated interferon γ-induced PD-L1 protein expression in vitro and CD68 positive macrophage infiltration in tumor xenograft.
    Wu, Jeffrey
    Neuwelt, Alexander J.
    Muldoon, Leslie L.
    Neuwelt, Edward A.
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (04) : 78 - 78